TIMOTHY LANIER: Open Payments
NPI 1992459457 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 34 payments from 12 companies in 2025. Trend: 2023 $1,041 · 2024 $939 · 2025 $1,195
Food & beverage: $1,195
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $378 |
| Amgen Inc. | 6 | $216 |
| GlaxoSmithKline, LLC. | 9 | $152 |
| Intra-Sana Laboratories | 1 | $141 |
| Novo Nordisk Inc | 1 | $112 |
| Lilly USA, LLC | 2 | $39 |
| Renalytix AI, Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $31 |
| Gilead Sciences, Inc. | 1 | $30 |
| Corcept Therapeutics | 1 | $25 |
Products named: BREZTRI, TRELEGY ELLIPTA, REPATHA, RELTONE 200 MG, Ozempic, FARXIGA, OTEZLA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
